One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
Table 3
One-year outcome in the AF cohort and the two groups with NVAF and VAF.
Event
All AF patients
Patients with NVAF
Patients with VAF
All-cause death, (%)
218 (11.4)
210 (12.4)
8 (5.1)
0.01
Cardiovascular death, (%)
146 (7.8)
127 (7.4)
3 (1.9)
0.02
Stroke/systemic embolism, (%)
84 (4.5)
81 (4.7)
3 (1.9)
0.16
Major bleeding, (%)
49 (2.6)
46 (2.7)
3 (1.9)
0.74
Intracranial bleeding, (%)
9 (0.5)
9 (0.6)
0 (0)
0.69
Nonmajor clinically significant bleeding, (%)
128 (6.9)
107 (6.3)
21 (13.5)
0.001
Hospital admission for cardiac cause, (%)
272 (14.6)
247 (14.5)
25 (16.0)
0.70
AF: atrial fibrillation; NVAF: nonvalvular AF; VAF: valvular AF. Calculations were performed after excluding the group that lost follow-up () plus those who were enrolled as in-patients who died during the index hospitalization, and had no data at 1-, 6-, and 12-month follow-up ().
